Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Arthralgia × Tamoxifen × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 245 Carcinoma, Intraductal, Noninfiltrating 21 Breast Carcinoma In Situ 17 Neoplasm Metastasis 14 Neoplasms 12 Breast Neoplasms, Male 11 Ovarian Neoplasms 8 Inflammatory Breast Neoplasms 6 Glioblastoma 5 Endometrial Neoplasms 5 Central Nervous System Neoplasms 4 Breast Cancer Female 4 Recurrence 3 Prostatic Neoplasms 3 Obesity 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Sleep Wake Disorders 2 Pancreatic Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Hot Flashes 2 Glioma 2 Fibroadenoma 2 ER+ Breast Cancer 2 Carcinoma, Lobular 2 Astrocytoma 2

Interventions

Letrozole 4 Anastrozole 4 Surveys and Questionnaires 3 Aromatase Inhibitors 3 exemestane 2 Testosterone 2 Fatty Acids, Omega-3 2 Exercise 2 Acupuncture Therapy 2 methyl hydroxyethyl cellulose 1 guizhi-shaoyao-zhimu decoction 1 canakinumab 1 Yoga 1 Walking 1 Vitamin B 12 1 Therapeutics 1 Tamoxifen 1 Occupational Therapy 1 Hyaluronic Acid 1 Glucosamine 1 Glucaric Acid 1 Gabapentin 1 Fish Oils 1 Educational Status 1 Docosahexaenoic Acids 1 Diphosphonates 1 Diet Therapy 1 Denosumab 1 Curcumin 1 Chondroitin Sulfates 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01896050 2016-06-28

LOGRIBMET

University of Michigan Rogel Cancer Center

115 enrolled 14 charts

Breast Neoplasms, Obesity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡